Evaluation of In Vivo CAR Transgene Levels in Relapsed/Refractory Pediatric and Young Adult ALL and Adult DLBCL Tisagenlecleucel-Treated Patients
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Rakesh Awasthi, Karen Thudium Mueller, Gregory A. Yanik, Constantine S. Tam, Susana Rives, Joseph P. McGuirk, Michael A. Pulsipher, Michael W. Boyer, Ulrich Jaeger, Andre Baruchel, Gary Douglas Myers, Hyatt Balke-Want, Stephen J. Schuster, Heather Stefanski, Michael R. Bishop, Edward R. Waldron, Özlem Anak, Abhijit Chakraborty, Eric Bleickardt, Stephane Wong, Lida Bubuteishvili Pacaud, Edmund K. Waller, Shannon L. Maude
Institutions: C. S. Mott Children's Hospital, The University of Melbourne, Peter MacCallum Cancer Centre, St Vincent's Hospital Melbourne, Hospital Sant Joan de Déu Barcelona, University of Kansas Medical Center, University of Southern California, Children's Hospital of Los Angeles, University of Utah, Medical University of Vienna, Assistance Publique – Hôpitaux de Paris, Hôpital Robert-Debré, Children's Mercy Hospital, University Hospital Cologne, Abramson Cancer Center, University of Pennsylvania, University of Minnesota, University of Chicago, University of Chicago Medical Center, Novartis (Switzerland), Emory University, Winship Cancer Institute, Children's Hospital of Philadelphia
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2907012610